Clinical Trials

News

China NMPA accepts Astellas’ sBLA for urothelial cancer treatment

The sBLA is based on the data from the randomised, open-label, controlled Phase III EV-302 clinical trial.

close

Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close